| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Enhances Activation Of The Adenylyl Cyclase Signal Transduction Cascade
Departments of Medicine and Psychiatry, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205
Expression of the stimulatory G protein,
Gs
, can vary over a 3-fold range in human
tissues and in rodent central nervous system. In fact, the offspring of
alcoholics have higher levels of Gs
expression in certain tissues compared with the offspring of
nonalcoholics. The aim of this research was to test the hypothesis that
a causal relationship exists between the level of expression of
Gs
and induction of the adenylyl cyclase
(AC) cascade. The methodology employed transient transfection of HEK
293 cells with a cDNA for the 52-kDa form of
Gs
under regulation by inducible
metallothionein promoters. Transfectants were exposed to varying
concentrations (0125 µM) of zinc sulfate
that produced a 3-fold range of membrane Gs
expression. The range of Gs
expression
produced was found to mimic a physiologically relevant spectrum of
Gs
expression in membranes derived from
human tissues and rat brain. It was observed that induction of
Gs
expression increased constitutive as well
as stimulated cAMP accumulation. Moreover, induction of
Gs
expression increased events distal to the
accumulation of cAMP including the phosphorylation of the transcription
factor, cAMP response element binding protein and transcriptional
activation of cAMP-dependent reporter genes. In summary, these studies
show that the amount of Gs
expression has a
marked impact on the level of activity of the AC cascade from the
membrane through to the nucleus. It is hypothesized that individuals
who differ in Gs
expression may also differ
in the expression of certain cAMP-dependent genes.
This article has been cited by other articles:
![]() |
G. F. Lehnerdt, P. Franz, A. Zaqoul, K. J. Schmitz, S. Grehl, S. Lang, K. W. Schmid, W. Siffert, K. Jahnke, and U. H. Frey Overall and Relapse-Free Survival in Oropharyngeal and Hypopharyngeal Squamous Cell Carcinoma Are Associated with Genotypes of T393C Polymorphism of the GNAS1 Gene Clin. Cancer Res., March 15, 2008; 14(6): 1753 - 1758. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Romano, K. Magalon, M. Pertuit, R. Rasolonjanahary, A. Barlier, A. Enjalbert, and C. Gerard Conditional Overexpression of the Wild-Type Gs{alpha} as the gsp Oncogene Initiates Chronic Extracellularly Regulated Kinase 1/2 Activation and Hormone Hypersecretion in Pituitary Cell Lines Endocrinology, June 1, 2007; 148(6): 2973 - 2983. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. H. Frey, H. Nuckel, L. Sellmann, D. Siemer, R. Kuppers, J. Durig, U. Duhrsen, and W. Siffert The GNAS1 T393C Polymorphism Is Associated with Disease Progression and Survival in Chronic Lymphocytic Leukemia. Clin. Cancer Res., October 1, 2006; 12(19): 5686 - 5692. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. V. Selkirk, L. M. Nottebaum, I. C. Ford, M. Santos, S. Malany, A. C. Foster, and S. M. Lechner A Novel Cell-Based Assay for G-Protein-Coupled Receptor-Mediated Cyclic Adenosine Monophosphate Response Element Binding Protein Phosphorylation J Biomol Screen, June 1, 2006; 11(4): 351 - 358. [Abstract] [PDF] |
||||
![]() |
U. H. Frey, G. Lummen, T. Jager, K.-H. Jockel, K. W. Schmid, H. Rubben, N. Muller, W. Siffert, and A. Eisenhardt The GNAS1 T393C Polymorphism Predicts Survival in Patients with Clear Cell Renal Cell Carcinoma Clin. Cancer Res., February 1, 2006; 12(3): 759 - 763. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Tyson-Capper, J. Bailey, A. R. Krainer, S. C. Robson, and G. N. Europe-Finner The Switch in Alternative Splicing of Cyclic AMP-response Element Modulator Protein CREM{tau}2{alpha} (Activator) to CREM{alpha} (Repressor) in Human Myometrial Cells Is Mediated by SRp40 J. Biol. Chem., October 14, 2005; 280(41): 34521 - 34529. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. H. Frey, H. Alakus, J. Wohlschlaeger, K. J. Schmitz, G. Winde, H. G. van Calker, K.-H. Jockel, W. Siffert, and K. W. Schmid GNAS1 T393C Polymorphism and Survival in Patients with Sporadic Colorectal Cancer Clin. Cancer Res., July 15, 2005; 11(14): 5071 - 5077. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. H. Frey, A. Eisenhardt, G. Lummen, H. Rubben, K.-H. Jockel, K. W. Schmid, and W. Siffert The T393C Polymorphism of the G{alpha}s Gene (GNAS1) Is a Novel Prognostic Marker in Bladder Cancer Cancer Epidemiol. Biomarkers Prev., April 1, 2005; 14(4): 871 - 877. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bailey, A. J Tyson-Capper, K. Gilmore, S. C Robson, and G N. Europe-Finner Identification of human myometrial target genes of the cAMP pathway: the role of cAMP-response element binding (CREB) and modulator (CREM{alpha} and CREM{tau}2{alpha}) proteins J. Mol. Endocrinol., February 1, 2005; 34(1): 1 - 17. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Kull, P. Svenningsson, and B. B. Fredholm Adenosine A2A Receptors are Colocalized with and Activate Golf in Rat Striatum Mol. Pharmacol., October 1, 2000; 58(4): 771 - 777. [Abstract] [Full Text] |
||||
![]() |
J. Bailey, C. Sparey, R. J. Phillips, K. Gilmore, S. C. Robson, W. Dunlop, and G.N. Europe-Finner Expression of the cyclic AMP-dependent transcription factors, CREB, CREM and ATF2, in the human myometrium during pregnancy and labour Mol. Hum. Reprod., July 1, 2000; 6(7): 648 - 660. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Carel, C. Le Stunff, L. Condamine, E. Mallet, J. L. Chaussain, P. Adnot, M. Garabédian, and P. Bougnères Resistance to the Lipolytic Action of Epinephrine: A New Feature of Protein Gs Deficiency J. Clin. Endocrinol. Metab., November 1, 1999; 84(11): 4127 - 4131. [Abstract] [Full Text] |
||||
![]() |
A. Barlier, I. Pellegrini-Bouiller, G. Gunz, A. J. Zamora, P. Jaquet, and A. Enjalbert Impact of gsp Oncogene on the Expression of Genes Coding for Gs{alpha}, Pit-1, Gi2{alpha}, and Somatostatin Receptor 2 in Human Somatotroph Adenomas: Involvement in Octreotide Sensitivity J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2759 - 2765. [Abstract] [Full Text] |
||||
![]() |
E. Ballaré, S. Mantovani, A. Lania, A. M. Di Blasio, L. Vallar, and A. Spada Activating Mutations of the Gs{alpha} Gene Are Associated with Low Levels of Gs{alpha} Protein in Growth Hormone-Secreting Tumors J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4386 - 4390. [Abstract] [Full Text] |
||||
![]() |
A. Barlier, G. Gunz, A. J. Zamora, I. Morange-Ramos, D. Figarella-Branger, H. Dufour, A. Enjalbert, and P. Jaquet Pronostic and Therapeutic Consequences of Gs{alpha} Mutations in Somatotroph Adenomas J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1604 - 1610. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |